Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ MalayafiledCriticalUniv Malaya
Priority to MYPI20092756priorityCriticalpatent/MY151198A/en
Publication of MY151198ApublicationCriticalpatent/MY151198A/en
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicines Containing Plant Substances
(AREA)
Abstract
THE INVENTION PROVIDES A GROUP OF MEDICAMENT FOR TREATING FLAVIVIRUS INFECTION, SUCH AS THE SEROTYPE 2 DENGUE VIRAL INFECTION IN HUMAN BODY. THE INHIBITORS CAN BE EXTRACTED AND/OR PURIFIED PLANT SPECIES SUCH AS BOESENBERGIA ROTUNDA, BOESENBERGIA PANDURATA AND THE LIKES. THESE MEDICAMENTS SHALL COMPRISE OF THERAPEUTICALLY EFFECTIVE AMOUNT OF THE BIOACTIVE COMPOUNDS EXTRACTED FROM THE PLANT.
MYPI200927562009-06-292009-06-29A medicament for treating dengue
MY151198A
(en)
Therapeutic composition or medicament comprising a suspension of red corpuscles encapsulating asparginase for use in the treatment of pancreatic cancer
Composition for preventing or treating obesity-related diseases mediated by the activation of ampk and including 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignans as active ingredients
Substituted (2-oxo-1,3-oxazolidin-5-yl)methyl-thiophene-2-carboxamides, process for preparing same and use thereof for preparing medicaments for the treatment and/or prophylaxis of diseases